CAR-T Cells Targeting Autoimmune Diseases

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Autoimmune Diseases

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China
Contact: Study coordinator (Lung-Ji Chang, PhD) · c@szgimi.org · +86 0755-86573763

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of NEUK203-215 Injection in Adult Chinese Patients With Relapsed/Refractory Autoimmune Diseases

Autoimmune

Abroad (travel likely)RecruitingEARLY_PHASE1

Shanghai, China

Glycosylation Analysis of Lupus Anti-DNA Antibodies (GALA)

Lupus Erythematosus Disseminatus · Autoimmune Diseases · Chronic Disease

Abroad (travel likely)Recruiting

Montpellier, France · Nîmes, France

The Distribution of Immunoglobulin Isotype in Polyclonal Hypergammaglobulinemia in Systemic and Autoimmune Diseases

Polyclonal Hypergammaglobulinemia · Autoimmune Diseases

Abroad (travel likely)Recruiting

Amiens, France

China National Registry of Neuro-Inflammatory Diseases

Multiple Sclerosis · NMO Spectrum Disorder · Clinically Isolated Syndrome

Abroad (travel likely)Recruiting

Beijing, China